Pharmacology research & perspectives.

ISSN 2052-1707Wiley-Blackwell Publishing LtdUnited Kingdom
ScopusMEDLINEEmbasePubMedPMCSCImagoDOAJJIFMatched via identifier

Journal overview

Titles
Pharmacology Research and Perspectives
Pharmacol. Res. Perspect. (abbreviated)
Pharmacology Research & Perspectives
Pharmacol Res Perspect (abbreviated)
Pharmacology Research & Perspectives JOHN WILEY & SONS LTD
Pharmacology research & perspectives.
ISSN
2052-1707
eISSN
2052-1707
NLM ID
101626369
Publisher
Wiley-Blackwell Publishing Ltd
John Wiley and Sons Inc
Wiley
[Hoboken, NJ] : John Wiley & Sons Ltd, British Pharmacological Society andAmerican Society for Pharmacology and Experimental Therapeutics, [2013]-
Country
Language
ENG
English

Indexing & coverage

Scopus
Currently indexed

Scopus's Sources record lists this journal as active.

Indexing history
Coverage
2013–2026
Indexing services (MEDLINE, Embase)
MEDLINECurrently indexedEmbaseListed

Embase's Active journals record lists this journal as active.

Bibliographic inclusion (PubMed)
PubMedIncluded
Full-text availability (PMC — not an indexing service)
PMCCoverage available

Metrics

MetricYearValueQuartileRankSource
JIF20252.3Q37030JCR Impact Factor List 2025 — supplied dataset
SCImago Journal Rank (SJR) — 2025

Source: SCImago Journal & Country Rank — 2025 dataset. SJR is a metric published by SCImago, presented here as reported.

SJR
0.742
Best Quartile
Q1
H-index
53
Subject categories (quartile varies by category)
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous) — Q1
  • Neurology — Q2
More metrics
Coverage
2013–2026
Country
United Kingdom
Region
Western Europe
Publisher
Wiley-Blackwell Publishing Ltd
Open Access
Yes
Open Access (Diamond)
No
Total documents (current year)
157
Total documents (3 years)
370
Total references
7160
Total citations (3 years)
984
Citable documents (3 years)
352
Citations per document (2 years)
2.48
References per document
45.61
Source details
Match confidence
Probable — one matching ISSN
Matched via ISSN(s)
2052-1707
SCImago Source ID
21100825823
SCImago Rank (across all SCImago source types)
7662

Publication activity

Publication activity
2025
157 observed publications
Latest publication activity observed
2025
Current-year activity
Recent publication activity observed

Evidence sources: SCImago. SCImago's count is a source-reported aggregate figure; Crossref/OpenAlex/PubMed counts are distinct article records JCF Labs observed via each provider's own free API — none is guaranteed to be that journal's complete output for the year, and providers may disagree (this is expected, not an error). See this journal's own source evidence above for full context.

Open access

DOAJ — Directory of Open Access Journals

Source: DOAJ (Directory of Open Access Journals). Listing status and policy details are reported here as DOAJ published them.

Listed in DOAJ
Yes
License
CC BY, CC BY-NC, CC BY-NC-ND
APC (article processing charge)
3130 EUR; 2700 GBP; 4280 USD
More information
Waiver policy
Yes
Review process
Anonymous peer review
Plagiarism screening
Yes
Preservation services
CLOCKSS, PMC, Portico
Added to DOAJ
2016-01-26
Journal homepage
DOAJ profile
Source details
Match confidence
Probable — one matching ISSN
Matched via ISSN(s)
2052-1707

Subjects & categories

Subject area (SCImago)
MeSH (PubMed)
Drug Discovery; Pharmacological Phenomena; Translational Research, Biomedical.
Scopus:2013-2026
MEDLINE:MEDLINE: v5n1, Feb. 2017-In: PubMed: v1n1, 2013-, PMC;
PubMed:MEDLINE: v5n1, Feb. 2017-In: PubMed: v1n1, 2013-, PMC;
PMC:v.1(1) 2013 – v.14(5) 2026